CPHI vs PSX · rev $4.1M vs P/E 17, rev $143.15B
China Pharma Holdings Inc (CPHI) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
CPHI currently screens at market cap $29.0M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the CPHI and PSX stock pages for the full models.
Not investment advice.